Skip to main content
Dechra Pharmaceuticals PLC logo

Dechra Pharmaceuticals PLC — Investor Relations & Filings

Ticker · DPH ISIN · US2434351043 LEI · 213800J4UVB5OWG8VX82 IL Manufacturing
Open in API
Filings indexed 1,018 across all filing types
Latest filing 2020-09-22 Proxy Solicitation & In…
Country GB United Kingdom
Listing IL DPH

About Dechra Pharmaceuticals PLC

https://www.dechra.com/

Dechra Pharmaceuticals PLC is a global specialist business focused on veterinary pharmaceuticals and related products. The company's expertise encompasses the development, manufacture, marketing, and sale of high-quality veterinary medicines. Its product portfolio includes both novel and differentiated generic pharmaceuticals, with a significant focus on products for companion animals. Dechra provides solutions and support to veterinary professionals worldwide to improve animal health and welfare.

Recent filings

Filing Released Lang Actions
DECHRA PHARMACEUTICALS PLC 2020 NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a 'Chairman's Letter and Notice of Annual General Meeting' for Dechra Pharmaceuticals PLC. It contains the formal notice of the meeting, explanations of resolutions to be voted upon (including director elections, auditor appointment, and remuneration policy), and instructions for shareholders regarding proxy voting and attendance. This is a classic proxy statement/notice of meeting document sent to shareholders to solicit their votes for the upcoming AGM.
2020-09-22 English
DECHRA PHARMACEUTICALS PLC 2020 ANNUAL REPORT
Annual Report Classification · 100% confidence The document is explicitly titled 'Annual Report and Accounts for the year ended 30 June 2020' for Dechra Pharmaceuticals PLC. It contains comprehensive sections including a Strategic Report, Governance, Financial Statements, and Independent Auditors' Report, which are characteristic of a full annual report (10-K equivalent for UK-listed companies). FY 2020
2020-09-22 English
Annual Financial Report
Regulatory Filings Classification · 98% confidence The document is very short (2949 characters) and its primary purpose is to announce that several key documents—specifically the 'Annual Report and Accounts for the year ended 30 June 2020', 'Notice of Annual General Meeting', and 'Proxy Form'—have been mailed to shareholders and submitted to the FCA viewing facility. It explicitly states that these documents are now available to view on the company's website. According to Rule 2 ('MENU VS MEAL' Rule), when a document is short and announces the publication or availability of a full report, it should be classified as a Report Publication Announcement (RPA). Although it mentions the Annual Report and AGM materials, the text itself is just the announcement of their release.
2020-09-22 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is an official notification disseminated via RNS (London Stock Exchange news service) concerning a transaction involving shares by a Director and Person Discharging Managerial Responsibilities (PDMR), specifically Ian Page. This type of filing, detailing personal share transactions by executives, directly corresponds to the definition of Director's Dealing. The structure includes the RNS number, date, details of the PDMR, and a formal 'Notification of Dealing Form' as required under MAR Article 19.3. This clearly maps to the 'Director's Dealing' category (DIRS).
2020-09-18 English
Director/PDMR Shareholding
Director's Dealing Classification · 100% confidence The document is titled 'Notification of Transactions by Persons Discharging Managerial Responsibilities' and details the sale of shares by a Director (Julian Heslop). It explicitly mentions compliance with Article 19.3 of MAR (Market Abuse Regulation) and provides a detailed 'Notification of Dealing Form'. This type of filing, reporting insider transactions by directors/executives, directly corresponds to the definition of Director's Dealing (DIRS). Although it is distributed via RNS, the specific content dictates the DIRS classification over the general RNS fallback.
2020-09-18 English
Block listing Interim Review
Remuneration Information Classification · 99% confidence The document is explicitly titled 'BLOCK LISTING SIX MONTHLY RETURN' and is disseminated via 'RNS Number', which stands for Regulatory News Service, a primary information provider for the London Stock Exchange. This type of filing reports on the status of unallotted securities under various share option schemes over a six-month period (March 15, 2020, to September 14, 2020). This is a specific regulatory disclosure related to share capital management, but it does not fit the definitions for Share Issue/Capital Change (SHA) or Transaction in Own Shares (POS) which usually relate to actual issuance/repurchase events or announcements. Since it is a mandatory, periodic regulatory filing that doesn't fit the more specific categories like 10-K, ER, or DIRS, the most appropriate classification is the general regulatory filing category, RNS, as it is a standard announcement disseminated through that system.
2020-09-15 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.